Although environmental controls and immunotherapy have important roles in the management of rhinitis, pharmacotherapy is the mainstay of most treatment programs. Before effective pharmacotherapy can be instituted, correct diagnosis is required. There are rhinitis subtypes (allergic, nonallergic, or mixed), which influence pharmacologic choices. Correct diagnosis is, for a large part, reliant on collection of a thorough patient history. After correct diagnosis, a progressive management program can be developed. The effectiveness of the treatment program is dependent on accurate identification of the role allergic and nonallergic causes of rhinitis.
Document Type: Research Article
Publication date: May 1, 2003
More about this publication?
Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.